2024-11-19 18:44:18
Everest Medicines Initiates Submission of New Drug Application in Singapore for Sacituzumab Govitecan-Hziy for the Treatment of Metastatic Triple-Negative Breast Cancer
Corporate/ 2023-07-23
Everest Medicines Initiates Submission o...

SHANGHAI,Jan. 6,2021-- Everest Medicines (HKEX 1952.HK),a biopharmaceutical company focused on developing and commercializing transformative...

Everest Medicines Announces CTA Approval by China NMPA for Phase 3 Trial of Sacituzumab Govitecan-Hziy for Metastatic Urothelial Cancer
Corporate/ 2023-07-23
Everest Medicines Announces CTA Approval...

SHANGHAI,Jan. 6,2021--Everest Medicines (HKEX 1952.HK),a biopharmaceutical company focused on developing and commercializing transformative ...

CUSMail

CusMail provide the Latest News , Business and Technology News Release service. Most of our news is paid for distribution to meet global marketing needs. We can provide you with global market support.

© CUSMAIL. All Rights Reserved. Operate by Paid Release